NVIDIA
NVDA
Palantir
PLTR
Tesla
TSLA
4
Hims & Hers Health
HIMS
5
Tempus AI
TEM
US Stock MarketDetailed Quotes
CC The Chemours
- 15.470
- -0.680-4.21%
Trading Feb 25 11:03 ET
2.31BMarket Cap27.14P/E (TTM)
16.315High14.940Low1.45MVolume16.000Open16.150Pre Close22.65MTurnover0.98%Turnover Ratio27.14P/E (Static)149.44MShares28.40852wk High3.83P/B2.29BFloat Cap14.94052wk Low1.00Dividend TTM148.31MShs Float44.189Historical High6.46%Div YieldTTM8.51%Amplitude2.295Historical Low15.577Avg Price1Lot Size
The Chemours Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -4.87%5.78B | -1.27%1.39B | 0.94%1.5B | -6.39%1.54B | -12.11%1.35B | -11.02%6.08B | 2.69%1.41B | -16.32%1.49B | -14.20%1.64B | -12.93%1.54B |
| Operating revenue | -4.87%5.78B | -1.27%1.39B | 0.94%1.5B | -6.39%1.54B | -12.11%1.35B | -11.02%6.08B | 2.69%1.41B | -16.32%1.49B | -14.20%1.64B | -12.93%1.54B |
| Cost of revenue | -2.95%4.63B | -3.11%1.12B | 0.08%1.22B | -0.08%1.23B | -8.90%1.06B | -8.49%4.77B | -1.36%1.16B | -9.74%1.21B | -13.05%1.23B | -8.61%1.17B |
| Gross profit | -11.87%1.15B | 7.06%273M | 4.76%286M | -25.37%306M | -22.28%286M | -19.18%1.31B | 26.24%255M | -36.81%273M | -17.51%410M | -24.28%368M |
| Operating expense | -50.45%708M | -21.74%198M | -23.15%166M | -79.55%165M | 14.29%176M | 72.17%1.43B | 22.82%253M | 24.86%216M | 189.25%807M | -10.47%154M |
| Selling and administrative expenses | -54.65%585M | -24.22%169M | -18.18%135M | -82.16%139M | 16.13%144M | 81.69%1.29B | 27.43%223M | 17.86%165M | 206.69%779M | -12.06%124M |
| -General and administrative expense | ---- | ---- | ---- | ---- | 16.13%144M | ---- | ---- | ---- | ---- | --124M |
| Research and development costs | 0.93%109M | 0.00%26M | 3.57%29M | -7.14%26M | 7.69%28M | -8.47%108M | -13.33%26M | -12.50%28M | 12.00%28M | -13.33%26M |
| Other operating expenses | -54.84%14M | -25.00%3M | -91.30%2M | ---- | 0.00%4M | 1,450.00%31M | 300.00%4M | 2,200.00%23M | ---- | 300.00%4M |
| Operating profit | 460.16%443M | 3,650.00%75M | 110.53%120M | 135.52%141M | -48.60%110M | -115.65%-123M | 150.00%2M | -77.99%57M | -282.11%-397M | -31.85%214M |
| Net non-operating interest income expense | -26.92%-264M | -6.35%-67M | -25.45%-69M | -37.50%-66M | -50.00%-63M | -27.61%-208M | -57.50%-63M | -34.15%-55M | -20.00%-48M | -2.44%-42M |
| Non-operating interest expense | 26.92%264M | 6.35%67M | 25.45%69M | 37.50%66M | 50.00%63M | 27.61%208M | 57.50%63M | 34.15%55M | 20.00%48M | 2.44%42M |
| Other net income (expense) | -500.00%-52M | 109.09%1M | -836.36%-81M | -41.67%7M | 1,900.00%20M | -88.98%13M | 56.00%-11M | -86.42%11M | -77.36%12M | -85.71%1M |
| Gain on sale of security | 76.32%-9M | 82.35%-3M | ---- | -40.00%-7M | 114.29%1M | -153.33%-38M | 34.62%-17M | -169.23%-9M | -66.67%-5M | ---7M |
| Earnings from equity interest | -4.44%43M | 28.57%9M | -15.38%11M | -15.38%11M | 8.33%13M | -18.18%45M | -36.36%7M | -18.75%13M | -18.75%13M | 9.09%12M |
| Special income (charges) | -669.23%-100M | -50.00%-6M | -5,050.00%-99M | -400.00%-3M | 125.00%3M | -192.86%-13M | 63.64%-4M | -77.78%2M | -96.00%1M | -33.33%-12M |
| -Less：Restructuring and merger&acquisition | -62.30%46M | -37.50%5M | -58.25%43M | 400.00%3M | --0 | 771.43%122M | 60.00%8M | 5,250.00%103M | -200.00%-1M | 20.00%12M |
| -Less:Impairment of capital assets | --56M | --0 | --56M | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
| -Less:Other special charges | 0.00%1M | ---- | ---- | ---- | ---- | 114.29%1M | --0 | 114.29%1M | ---- | ---- |
| -Gain on sale of property,plant,equipment | -97.27%3M | --0 | --0 | --0 | --3M | 423.81%110M | 166.67%4M | --106M | --0 | --0 |
| Other non- operating income (expenses) | -26.32%14M | -66.67%1M | 40.00%7M | 100.00%6M | -62.50%3M | -70.31%19M | 200.00%3M | -88.37%5M | -80.00%3M | 60.00%8M |
| Income before tax | 139.94%127M | 112.68%9M | -330.77%-30M | 118.94%82M | -61.27%67M | -142.91%-318M | -2.90%-71M | -95.65%13M | -287.45%-433M | -38.21%173M |
| Income tax | 150.62%41M | 132.08%17M | -400.00%-3M | 121.05%12M | -46.43%15M | -149.69%-81M | -289.29%-53M | -98.31%1M | -290.00%-57M | -39.13%28M |
| Net income | 136.29%86M | 55.56%-8M | -325.00%-27M | 118.62%70M | -64.14%52M | -141.00%-237M | 81.44%-18M | -95.00%12M | -287.06%-376M | -38.03%145M |
| Net income continuous Operations | 136.29%86M | 55.56%-8M | -325.00%-27M | 118.62%70M | -64.14%52M | -141.00%-237M | 81.44%-18M | -95.00%12M | -287.06%-376M | -38.03%145M |
| Minority interest income | 0 | 0 | 0 | 0 | 1M | 0 | 0 | 0 | ||
| Net income attributable to the parent company | 136.13%86M | 55.56%-8M | -325.00%-27M | 118.62%70M | -64.14%52M | -141.18%-238M | 81.44%-18M | -95.00%12M | -287.06%-376M | -38.03%145M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | 136.13%86M | 55.56%-8M | -325.00%-27M | 118.62%70M | -64.14%52M | -141.18%-238M | 81.44%-18M | -95.00%12M | -287.06%-376M | -38.03%145M |
| Basic earnings per share | 136.25%0.58 | 61.54%-0.05 | -325.00%-0.18 | 118.65%0.47 | -63.92%0.35 | -143.01%-1.6 | 77.59%-0.13 | -94.81%0.08 | -295.35%-2.52 | -33.56%0.97 |
| Diluted earnings per share | 135.63%0.57 | 53.85%-0.06 | -325.00%-0.18 | 118.25%0.46 | -64.58%0.34 | -143.84%-1.6 | 77.59%-0.13 | -94.74%0.08 | -300.00%-2.52 | -32.87%0.96 |
| Dividend per share | 0.00%1 | 0.00%0.25 | 0.00%0.25 | 0.00%0.25 | 0.00%0.25 | 0.00%1 | 0.00%0.25 | 0.00%0.25 | 0.00%0.25 | 0.00%0.25 |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |